Citation Impact

Citing Papers

A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease
2007
Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up
2010
Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process.
1994
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common.
1994
Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease
1998
Quantitative histological study of enteropathy associated with HIV infection.
1990
Chronic ulcerative colitis: incidence and prevalence in a community.
1987
Oral budesonide is as effective as oral prednisolone in active Crohn’s disease
1997
Omega-3 Fatty Acids in Health and Disease: Part 2—Health Effects of Omega-3 Fatty Acids in Autoimmune Diseases, Mental Health, and Gene Expression
2005
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Maintenance treatment of Crohn's disease
2003
Systemic and topical steroids in inflammatory bowel disease
2004
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Pancreatic cancer
2004 Standout
Management of Crohn's disease in adults
2001
n-3 Fatty acids for the treatment of inflammatory bowel diseases
2002
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial
2002
Review article: infliximab therapy for inflammatory bowel disease – seven years on
2006
Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease
1995
Dietary Intake and Bioavailability of Polyphenols
2000 Standout
Treatment of active Crohn's disease by exclusion diet: East Anglian Multicentre Controlled Trial
1993
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
2013
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study
2015
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Crohn's disease
2012 Standout
Oral Budesonide for Active Crohn's Disease
1994
How Rapidly Should Remission Be Achieved?
2010
Infliximab for patients with refractory ulcerative colitis
2001
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
The interplay between the intestinal microbiota and the brain
2012 Standout
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Life Events and Inflammatory Bowel Disease Relapse: A Prospective Study of Patients Enrolled in Remission
2006
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
1997 StandoutNature
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn’s disease
2005
External review and validation of the Swedish national inpatient register
2011 Standout
Cost of Illness of Crohn??s Disease
2002
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Inflammatory Bowel Disease
1991 Standout
Ulcerative colitis
2012 Standout
10 Adjuvant post-operative therapy
1998
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial
1999
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Inflammatory Bowel Disease
2002 Standout
Hospital discharges for inflammatory bowel disease
1990
The epidemiology of inflammatory bowel disease: A large, population-based study in Sweden
1991
Ingested matter affects intestinal lesions in Crohnʼs disease
2007
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Psychological stress in IBD: new insights into pathogenic and therapeutic implications
2005
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Budesonide as maintenance treatment in Crohn's disease: a placebo‐controlled trial
2005
Ulcerative colitis
2016 Standout
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Inflammatory Bowel Disease
1996
The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis
2012
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease
1999
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
2000
Increased intestinal permeability in malnourished patients with liver cirrhosis
2012
Survival and causes of death in patients with inflammatory bowel disease: A population-based study
1992
ESPEN Guidelines on Enteral Nutrition: Gastroenterology
2006
Enteral nutritional therapy for induction of remission in Crohn's disease
2001
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Advances in the management of Crohn's disease: economic and clinical potential of infliximab
1998
Review article: altering the natural history of Crohn's disease – evidence for and against current therapies
2006
Comparison of the Intestinal Absorption of Quercetin, Phloretin and Their Glucosides in Rats
2001
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease
2013
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
2002
Time Trends in the Incidence and Disease Location of Crohnʼs Disease 1980-1995: A Prospective Analysis in an Urban Population in Germany
1999
Clinical, biological, and endoscopic picture of attacks of Crohn's disease
1990
NUTRITION AND INFLAMMATORY BOWEL DISEASE
1999
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Ethanol metabolism and its effects on the intestinal epithelial barrier
2013
Bioavailability of Phloretin and Phloridzin in Rats
2001
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Lipid oxidation and improving the oxidative stability
2010 Standout
Short CDAI: Development and validation of a shortened and simplified Crohnʼs disease activity index
2010
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2011
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
Budesonide for Maintenance of Remission in Patients with Crohn's Disease in Medically Induced Remission: A Predetermined Pooled Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
2005
6‐Tioguanine monitoring in steroid‐dependent patients with inflammatory bowel diseases receiving azathioprine
2005
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Optimizing anti-TNF treatment in inflammatory bowel disease
2004
The limitations of corticosteroid therapy in Crohn’s disease
2001
Infectious disease complications of Gl endoscopy: Part I, endogenous infections
2003
Pancreatic cancer
2011 Standout
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study
2007
A Comparison of Budesonide and Mesalamine for Active Crohn's Disease
1998
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Recurrence after colectomy in Crohn's colitis
2001
Epidemiological aspects of Crohn's disease: a review of the literature.
1984
A classification of glycosyl hydrolases based on amino acid sequence similarities
1991 Standout
New steroids for IBD: progress report
2002
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
1993 Standout
Complete primary structure of human and rabbit lactase-phlorizin hydrolase: implications for biosynthesis, membrane anchoring and evolution of the enzyme.
1988
Maintenance Therapy in Crohn's Disease
2000
Budesonide versus prednisone in the treatment of active Crohn's disease
1998
Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982.
1988
Long‐Term Ethanol Feeding Enhances Susceptibility of the Liver to Orally Administered Lipopolysaccharides in Rats
2002
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease
2001
Gastrointestinal adaptation to diets of differing fat composition in human volunteers.
1991
Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort
2014
DNA Methylation Alterations in the Pancreatic Juice of Patients with Suspected Pancreatic Disease
2006
Comparison of enteral nutrition and drug treatment in active Crohn's disease
1991
Gluten, major histocompatibility complex, and the small intestine
1992 Standout
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Polyunsaturated fatty acids and inflammatory bowel disease
2000
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Budesonide for maintenance of remission in Crohn's disease
2014
Review article: integrating budesonide‐MMX into treatment algorithms for mild‐to‐moderate ulcerative colitis
2014
On the Identity between the Small Intestinal Enzymes Phlorizin Hydrolase and Glycosylceramidase
1973
Enteral nutritional therapy for induction of remission in Crohn's disease
2007
Lifestyle-related disease in Crohn’s disease: Relapse prevention by a semi-vegetarian diet
2010
Effect of Secreted Bacteroides Proteases on Human Intestinal Brush Border Hydrolases
1980
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Budesonide for induction of remission in Crohn's disease
2015
The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study
2008
Oral budesonide as maintenance therapy in Crohn’s disease—results of a 12‐month study
1998
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Preventing postoperative recurrence of Crohn's disease.
1997

Works of H. Lorenz‐Meyer being referenced

Comparative radiological and morphological study of human pancreas. Pancreatitis like changes in postmortem ductograms and their morphological pattern. Possible implication for ERCP.
1985
The influence of food intake on the development of structural and functional adaptation following ileal resection in the rat.
1975
Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.
1996
Omega-3 Fatty Acids and Low Carbohydrate Diet for Maintenance of Remission in Crohn's Disease: A Randomized Controlled Multicenter Trial
1996
A Comparison of Budesonide with Prednisolone for Active Crohn's Disease
1994
Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III.
1990
A Second Enzyme Defect in Acquired Lactase Deficiency: Lack of Small‐Intestinal Phlorizin‐Hydrolase
1972
Vergleich verschiedener morphometrischer Methoden zur Erfassung der Schleimhautoberfl�che des Rattend�nndarms und deren Beziehung zur Funktion
1976
Quantitative Histomorphometric Study of the Jejunal Mucosa in Chronic Alcoholics
1982
[Epidemiologic aspects of Crohn regional enterocolitis and ulcerative colitis in Marburg/Lahn (West Germany) between 1962 and 1975].
1983
Small intestinal phlorizin hydrolase: The “β-glycosidase complex”
1973
Functional, biochemical and morphological alterations in the intestines of rats with an experimental blind-loop syndrome
1975
European Cooperative Crohn’s Disease Study (ECCDS): Colonoscopy
1985
ERCP: Complications and Prophylaxis
1981
[Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study].
1981
Feasibility and Effectiveness of a Defined-Formula Diet Regimen in Treating Active Crohn's Disease
1990
[The correlation of psychosocial stress and disease activity in patients with Crohn disease and ulcerative colitis].
1988
Rankless by CCL
2026